June 20, 2014 — Less aggressive anticoagulation therapy, combined with low-dose aspirin, can be used safely in ...
Pharmaceuticals
This channel includes news and new technology innovations for cardiovascular pharmaceutics. This includes antiplatelet agents, anticoagulation drugs, INR testing, NOAC, OAC, IV administered drugs such as Heprin, and dual antiplatelet therapy.
June 17, 2014 — AtheroNova Inc. received a Notice of Issuance for an additional compound for cardiovascular treatments ...
June 10, 2014 — Mast Therapeutics Inc. announced that, in a placebo-controlled, nonclinical model of chronic heart ...
June 5, 2014 — Mercator MedSystems is in the midst of its prospective, 300-patient, 30-site DANCE (Dexamethasone to the ...
June 3, 2014 — Strokes kill nearly 130,000 Americans every year, according to the Centers for Disease Control and ...
June 3, 2014 — The U.S. Food and Drug Administration (FDA) announced it approved Zontivity (vorapaxar) tablets to reduce ...
May 30, 2014 — Alere announced a class I recall of its INRatio2 PT/INR professional test strips, part of the Alere ...
May 22, 2014 — Hospira Inc. issued a nationwide recall to the user level for one lot of Dobutamine Injection, USP, 250 ...
May 14, 2014 — The National Lipid Assn. (NLA) released a draft summary that highlights key aspects of care that provide ...
May 12, 2014 — New data presented for the first time at the World Heart Federation’s World Congress of Cardiology 2014 ...
May 6, 2014 — The National Lipid Association (NLA) recently convened an expert panel to examine various aspects of ...
April 29, 2014 — Armetheon Inc. announced it has reached agreement with the U.S. Food and Drug Administration (FDA) on a ...
April 21, 2014 — Decision Resources Group announced in a report that Servier's ivabradine (procoralan) is set to become ...

April 10, 2014 — The 2014 Guideline for the Management of Patients With Atrial Fibrillation includes recommendations for ...
April 9, 2014 — LipoScience Inc. announced data showing that patients managed to a target LDL particle (LDL-P) number ...